Carvedilol and Capoten drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carvedilol (carvedilol) and Capoten (captopril). Common drug interactions include productive cough among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Carvedilol and Capoten. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.

What is Capoten?

Capoten has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 2,954 Capoten users. Check the latest studies of Capoten.



On Jul, 18, 2026

48 people who take Carvedilol and Capoten together, and have interactions are studied.

Carvedilol and Capoten drug interactions.

What are the common drug interactions of Carvedilol and Capoten, by gender? *:

female:

  1. Productive cough
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Weight decreased
  5. Anaemia (lack of blood)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cardiac failure congestive
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Chills (felling of cold)
  10. Chronic kidney disease

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypotension (abnormally low blood pressure)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal cyst (kidney cyst)
  7. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  8. Asthenia (weakness)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Blood creatinine increased

What are the common drug interactions of Carvedilol and Capoten, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood creatinine increased
  2. Hypertensive crisis
  3. Renal impairment (severely reduced kidney function)
  4. Road traffic accident

30-39:

n/a

40-49:

  1. Fall
  2. Sudden death unexplained
  3. Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)

50-59:

  1. Renal injury (kidney injury)
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Benign prostatic hyperplasia (benign enlargement of the prostate)
  5. Constipation
  6. Dehydration (dryness resulting from the removal of water)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Dyslipidaemia (abnormal amount of lipids)
  9. Gout (uric acid crystals building up in the body)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

  1. Chest pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Pneumonia
  4. Renal failure (kidney dysfunction)
  5. Weight decreased
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Asthenia (weakness)
  8. Cardiac failure
  9. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 14.58%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 10.42%
  3. Diabetes: 5 people, 10.42%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 8.33%
  5. Cardiac Failure: 4 people, 8.33%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 8.33%
  7. Gastric Ulcer (stomach ulcer): 4 people, 8.33%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 8.33%
  9. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 4 people, 8.33%
  10. Oedema (fluid collection in tissue): 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and Capoten?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carvedilol and Capoten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carvedilol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Capoten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carvedilol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Capoten and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and captopril (the active ingredients of Carvedilol and Capoten, respectively), and Carvedilol and Capoten (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: